Cargando…

Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up

PURPOSE: Breast cancer-related lymphedema (BCRL) is caused by an interruption of the lymphatic system after breast cancer treatment. Lymphaticovenous anastomosis (LVA), by which one or more patent lymphatic collecting vessels are connected to subcutaneous veins, shows promising results. Postoperativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfs, Joost A. G. N., de Joode, Luuke G. E. H., van der Hulst, René R. W. J., Qiu, Shan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985198/
https://www.ncbi.nlm.nih.gov/pubmed/31542874
http://dx.doi.org/10.1007/s10549-019-05450-2
_version_ 1783491769913049088
author Wolfs, Joost A. G. N.
de Joode, Luuke G. E. H.
van der Hulst, René R. W. J.
Qiu, Shan S.
author_facet Wolfs, Joost A. G. N.
de Joode, Luuke G. E. H.
van der Hulst, René R. W. J.
Qiu, Shan S.
author_sort Wolfs, Joost A. G. N.
collection PubMed
description PURPOSE: Breast cancer-related lymphedema (BCRL) is caused by an interruption of the lymphatic system after breast cancer treatment. Lymphaticovenous anastomosis (LVA), by which one or more patent lymphatic collecting vessels are connected to subcutaneous veins, shows promising results. Postoperatively, the patency of these anastomosis can be evaluated; however, little is known concerning the long-term patency after LVA in patients with BCRL. The aim of this study was to analyse the long-term patency, quality of life (QoL) and arm circumference after LVA, and to explore differences between patent and non-patent anastomosis and its correlation with clinical improvement. METHODS: Twenty-five patients underwent indocyanine green (ICG) lymphography, lymph ICF-questionnaire, and arm circumference measurement preoperatively and 12 months after the LVA procedure. RESULTS: Seventy-six percent of the patients showed at least one patent anastomosis after 12 months. Quality of life according to the Lymph-ICF increased significantly (p < 0.000); however, arm circumference showed no significant decrease. Sixty-five percent discontinued wearing compression stockings. The patent anastomosis group, compared with the non-patent anastomosis group showed, without significance, more improvement in QoL, arm circumference, and discontinuation of compression stockings, as well as a lower rate of infections both pre- and postoperatively, a shorter duration of lymphedema preoperatively, and a higher rate of early lymphedema and ICG stage. CONCLUSIONS: LVA showed an acceptable patency and positive correlation between a patent anastomosis and clinical improvement after 12 months. Further research with a larger study population is required to determine whether outcomes or patient characteristics significantly correlate with a patent anastomosis after LVA operation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-019-05450-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6985198
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-69851982020-02-07 Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up Wolfs, Joost A. G. N. de Joode, Luuke G. E. H. van der Hulst, René R. W. J. Qiu, Shan S. Breast Cancer Res Treat Clinical Trial PURPOSE: Breast cancer-related lymphedema (BCRL) is caused by an interruption of the lymphatic system after breast cancer treatment. Lymphaticovenous anastomosis (LVA), by which one or more patent lymphatic collecting vessels are connected to subcutaneous veins, shows promising results. Postoperatively, the patency of these anastomosis can be evaluated; however, little is known concerning the long-term patency after LVA in patients with BCRL. The aim of this study was to analyse the long-term patency, quality of life (QoL) and arm circumference after LVA, and to explore differences between patent and non-patent anastomosis and its correlation with clinical improvement. METHODS: Twenty-five patients underwent indocyanine green (ICG) lymphography, lymph ICF-questionnaire, and arm circumference measurement preoperatively and 12 months after the LVA procedure. RESULTS: Seventy-six percent of the patients showed at least one patent anastomosis after 12 months. Quality of life according to the Lymph-ICF increased significantly (p < 0.000); however, arm circumference showed no significant decrease. Sixty-five percent discontinued wearing compression stockings. The patent anastomosis group, compared with the non-patent anastomosis group showed, without significance, more improvement in QoL, arm circumference, and discontinuation of compression stockings, as well as a lower rate of infections both pre- and postoperatively, a shorter duration of lymphedema preoperatively, and a higher rate of early lymphedema and ICG stage. CONCLUSIONS: LVA showed an acceptable patency and positive correlation between a patent anastomosis and clinical improvement after 12 months. Further research with a larger study population is required to determine whether outcomes or patient characteristics significantly correlate with a patent anastomosis after LVA operation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-019-05450-2) contains supplementary material, which is available to authorized users. Springer US 2019-09-21 2020 /pmc/articles/PMC6985198/ /pubmed/31542874 http://dx.doi.org/10.1007/s10549-019-05450-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Trial
Wolfs, Joost A. G. N.
de Joode, Luuke G. E. H.
van der Hulst, René R. W. J.
Qiu, Shan S.
Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
title Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
title_full Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
title_fullStr Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
title_full_unstemmed Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
title_short Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
title_sort correlation between patency and clinical improvement after lymphaticovenous anastomosis (lva) in breast cancer-related lymphedema: 12-month follow-up
topic Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985198/
https://www.ncbi.nlm.nih.gov/pubmed/31542874
http://dx.doi.org/10.1007/s10549-019-05450-2
work_keys_str_mv AT wolfsjoostagn correlationbetweenpatencyandclinicalimprovementafterlymphaticovenousanastomosislvainbreastcancerrelatedlymphedema12monthfollowup
AT dejoodeluukegeh correlationbetweenpatencyandclinicalimprovementafterlymphaticovenousanastomosislvainbreastcancerrelatedlymphedema12monthfollowup
AT vanderhulstrenerwj correlationbetweenpatencyandclinicalimprovementafterlymphaticovenousanastomosislvainbreastcancerrelatedlymphedema12monthfollowup
AT qiushans correlationbetweenpatencyandclinicalimprovementafterlymphaticovenousanastomosislvainbreastcancerrelatedlymphedema12monthfollowup